Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Hull Leavitt v. Alnylam Pharmaceuticals, Inc. et al
Case Number:
1:18-cv-12433
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
March 23, 2020
Alnylam Dodges Stock-Drop Suit Over FDA Approval Efforts
Alnylam Pharmaceuticals escaped a stock-drop suit Monday when a federal judge in Massachusetts dismissed investors' claims that the company made misleading statements about the FDA approval prospects for a drug to treat a rare disease.
-
May 08, 2019
Bernstein Liebhard Gets Lead Spot In Alnylam Stock Drop Suit
A Boston federal judge on Wednesday selected a lead plaintiff represented by Bernstein Liebhard and Berman Tabacco from among four candidates who were vying to represent a putative class of Alnylam Pharmaceuticals Inc. investors who lost money after a stock drop.